InvestorsHub Logo
Followers 54
Posts 3476
Boards Moderated 0
Alias Born 10/26/2013

Re: None

Thursday, 08/06/2020 5:05:17 PM

Thursday, August 06, 2020 5:05:17 PM

Post# of 3283
Second Quarter UDENYCA® Net Sales of $135.7M...Wow!

I had a dream (ok a thought but might as well be a dream) that Rolontis would be approved earlier than the PDUFA date due to the FDA's "familiarity" w Rolontis on account of the extra meetings that occurred to get Rolontis back on track for BLA submission. Hey, I thought pozi cohort 2 had a puncher's chance so Rolontis has a puncher's chance too but this time I really think it's in my dreams.